GAMBATO, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.418
AS - Asia 2.492
EU - Europa 1.698
AF - Africa 584
SA - Sud America 541
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 23
Totale 9.816
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.082
SG - Singapore 943
CN - Cina 480
IT - Italia 417
BR - Brasile 321
HK - Hong Kong 242
DE - Germania 180
VN - Vietnam 174
FI - Finlandia 131
PL - Polonia 106
SE - Svezia 87
GB - Regno Unito 76
NL - Olanda 76
FR - Francia 68
RU - Federazione Russa 48
IN - India 47
AT - Austria 44
MX - Messico 43
AR - Argentina 41
TR - Turchia 39
CA - Canada 32
ES - Italia 32
ID - Indonesia 32
IQ - Iraq 32
UA - Ucraina 29
BJ - Benin 28
IE - Irlanda 28
JP - Giappone 27
KR - Corea 26
ZA - Sudafrica 26
EC - Ecuador 24
TW - Taiwan 24
BY - Bielorussia 23
CO - Colombia 23
CR - Costa Rica 23
JO - Giordania 23
PY - Paraguay 23
GR - Grecia 22
PS - Palestinian Territory 22
CL - Cile 21
CV - Capo Verde 21
GH - Ghana 21
VE - Venezuela 21
AE - Emirati Arabi Uniti 20
CI - Costa d'Avorio 20
EE - Estonia 20
BO - Bolivia 19
JM - Giamaica 19
LB - Libano 19
MZ - Mozambico 19
SK - Slovacchia (Repubblica Slovacca) 19
SN - Senegal 19
UZ - Uzbekistan 19
BE - Belgio 18
CM - Camerun 18
GF - Guiana Francese 18
HR - Croazia 18
MG - Madagascar 18
MK - Macedonia 18
TJ - Tagikistan 18
ZM - Zambia 18
AM - Armenia 17
DK - Danimarca 17
GN - Guinea 17
IR - Iran 17
NO - Norvegia 17
NP - Nepal 17
NZ - Nuova Zelanda 17
PA - Panama 17
TN - Tunisia 17
BF - Burkina Faso 16
CY - Cipro 16
DZ - Algeria 16
GE - Georgia 16
GP - Guadalupe 16
HN - Honduras 16
LY - Libia 16
PK - Pakistan 16
RE - Reunion 16
RO - Romania 16
BD - Bangladesh 15
HU - Ungheria 15
KE - Kenya 15
LU - Lussemburgo 15
LV - Lettonia 15
NE - Niger 15
NI - Nicaragua 15
PH - Filippine 15
PR - Porto Rico 15
SA - Arabia Saudita 15
SI - Slovenia 15
SO - Somalia 15
UY - Uruguay 15
VC - Saint Vincent e Grenadine 15
AU - Australia 14
AZ - Azerbaigian 14
CD - Congo 14
CH - Svizzera 14
HT - Haiti 14
IL - Israele 14
Totale 9.172
Salva come PNG Salva come JPEG
Città #
Ashburn 546
Singapore 528
Fairfield 509
Chandler 307
Ann Arbor 300
Woodbridge 245
Hong Kong 233
Houston 222
Cambridge 184
Seattle 183
Beijing 155
Wilmington 131
Santa Clara 109
Boardman 84
San Diego 77
Los Angeles 75
Munich 71
Bytom 69
Des Moines 67
Padova 67
Helsinki 59
Medford 57
Princeton 57
Dong Ket 53
Milan 51
Ho Chi Minh City 44
New York 42
Roxbury 37
Chicago 32
Turku 32
São Paulo 30
Guangzhou 27
Hefei 27
Nanjing 27
Hanoi 26
Cotonou 25
Amman 23
Buffalo 23
Dublin 23
London 23
Nuremberg 22
Warsaw 20
Abidjan 19
Dakar 19
Villafranca Padovana 19
Accra 18
Antananarivo 18
Johannesburg 18
Lusaka 18
San José 18
Tashkent 18
Vienna 18
Conakry 17
Dushanbe 17
Praia 17
Stockholm 17
Shenyang 16
Tallinn 16
Kingstown 15
Managua 15
Panama City 15
Rome 15
Boston 14
Castries 14
Frankfurt am Main 14
Kampala 14
Maputo 14
Minsk 14
Padua 14
Redondo Beach 14
Baku 13
Bamako 13
Bridgetown 13
Brooklyn 13
Kingston 13
Montreal 13
Nairobi 13
Niamey 13
Seoul 13
Yerevan 13
Athens 12
Douala 12
Lappeenranta 12
Montevideo 12
Nassau 12
Shanghai 12
Skopje 12
Tbilisi 12
Tokyo 12
Tripoli 12
Ulan Bator 12
Auckland 11
Bishkek 11
Denver 11
Libreville 11
Podgorica 11
San Juan 11
Vientiane 11
Chennai 10
Dili 10
Totale 5.736
Salva come PNG Salva come JPEG
Nome #
Frailty and sarcopenia in patients with cirrhosis awaiting liver transplantation: evidence from a single-centre, prospective cohort study 247
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study 239
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 219
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics 217
Short-term outcomes of pediatric liver transplant recipients after transition to Adult Healthcare Service 190
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 180
A Longitudinal, Prospective Study On Adherence To Medical Regimen Before and After Liver Transplantation 173
Female gender in the setting of liver transplantation. 169
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 167
Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation 165
DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue? 162
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 162
Meld-na and Survival Benefit In Liver Transplantation 160
Management of portal hypertension severe complications 160
Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study 159
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 159
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 158
Chest X-ray Interpretation: Detecting Devices and Device-Related Complications 158
De Novo Tumors after Liver Transplantation: Results from a Multicentric Study, Italy 1990-2008 156
Who Fares Worse After Liver Transplantation? Impact of Donor and Recipient Variables on Outcome: Data from a Prospective Study. 156
USE OF ANTI-HBc POSITIVE DONORS IN LIVER TRANSPLANTATION: THE EXPERIENCE OF PADUA LIVER TRANSPLANT CENTRE 154
A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS-CoV-2 infection 154
Italian practical clinical guidelines on cholangiocarcinoma: Part II, Treatment 152
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study 150
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy 150
Liver Transplantation In Cirrhotic Patients With Meld Score < 18: A New Prognostic Model To Predict Drop-out From the Waiting List 149
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation 147
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. 147
Model for End-Stage Liver Disease-Sodium and Survival Benefit in Liver Transplantation. 146
A New Allocation Model For Liver Transplantation Combining Urgency Based Prioritization With Donor-recipient Matching: A Prospective Controlled Study 146
Prioritization Tools To Predict Short and Long Term Mortality Following Liver Transplantation 144
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma 144
Drug induced liver injury: from pathogenesis to liver transplantation 142
Does Once-Daily Tacrolimus (Advagraf) Increase Adherence to Immunosuppressive Therapy in Liver Transplanted Patients? 141
Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis 140
In-Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment 139
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting 137
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part I: Classification, diagnosis and staging 137
Evolution of Liver Transplantation Indications: Expanding Horizons 135
Self-Reported Adherence to Medical Prescriptions before and after Liver Transplantation: A Longitudinal Study 135
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation 134
Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy 132
Liver transplantation for viral hepatitis in 2015 131
Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology 130
Trends in liver transplantation for primary sclerosing cholangitis 128
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection 123
New indications for liver transplantation 123
Management of hepatocellular carcinoma recurrence after liver transplantation 121
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept 120
Estimation of the Harm To the Waiting List As Crucial Factor In the Selection of Patients With Hepatocellular Carcinoma For Liver Transplantation 119
Prospective Evaluation of Long Term Cognitive and Neurological Alterations in Liver Transplanted Patients with Central Pontine (CPM) and Extrapontine Myelinolysis (EPM) 117
Malnourished cirrhotic patient: what should we do? 117
Incidence of De Novo Tumors after Liver Transplantation: Results from a Multicentric Study, Italy 1990-2009 104
Impact of Donor-Recipient Risk Factors on Patient and Graft Survival after Liver Transplantation? A Single Centre Experience 104
Extending transplantation criteria for hepatocellular carcinoma 104
Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor 103
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation 103
Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis 101
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool 97
Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) 97
Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review 96
Bacterial Infections in End-Stage Liver Disease: Implications for Liver Transplantation 94
Host and virological features of HCV infection in liver transplant setting 93
Efficacy of immunotherapy in hepatocellular carcinoma: Does liver disease etiology have a role? 93
Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study 92
Invasive fungal infection before and after liver transplantation 89
The Italian experience on liver transplantation for unresectable peri-hilar cholangiocarcinoma: a national survey and future perspectives 88
Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data 86
Recent advances in the management of acute variceal hemorrhage 86
Reply 76
The impact of age and frailty on hospitalization and survival in older liver transplant recipients: a longitudinal cohort study 73
Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship 66
Impact of Recipient MELD and Na plus , Donor Age on Short Patient Survival Following Liver Transplantation 64
Chronic Hepatitis B in the Transplant Setting: A 30-Year Experience in a Single Tertiary Italian Center 59
Totale 9.908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.853
article - articoli 32.468
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.321
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021393 0 0 0 0 0 14 29 43 77 95 41 94
2021/2022877 46 107 62 36 41 118 78 50 37 52 79 171
2022/2023613 103 72 20 76 100 81 12 39 56 3 45 6
2023/2024440 30 68 45 34 36 46 55 24 20 19 23 40
2024/20251.965 4 139 96 88 198 72 99 131 161 75 347 555
2025/20264.136 456 600 1.062 1.300 697 21 0 0 0 0 0 0
Totale 9.908